Europe Anti-Infective Agents Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Anti-Infective Agents Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Anti-Infective Agents Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Anti-Infective Agents Market Regional Analysis

6.2 Europe Anti-Infective Agents Market Revenue 2020-2028 (US$ Million)

6.3 Europe Anti-Infective Agents Market Forecast Analysis

7. Europe Anti-Infective Agents Market Analysis – by Type

7.1 Anti-Viral

7.1.1 Overview
7.1.2 Anti-Viral: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Anti-Bacterial

7.2.1 Overview
7.2.2 Anti-Bacterial: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Anti-Fungal

7.3.1 Overview
7.3.2 Anti-Fungal: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Anti-Infective Agents Market Analysis – by Range

8.1 Narrow Spectrum and Broad Spectrum

8.1.1 Overview
8.1.2 Narrow Spectrum and Broad Spectrum: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Anti-Infective Agents Market Analysis – by Route of Administration

9.1 IV

9.1.1 Overview
9.1.2 IV: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Oral

9.2.1 Overview
9.2.2 Oral: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Topical

9.3.1 Overview
9.3.2 Topical: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Anti-Infective Agents Market Analysis – by Indication

10.1 HIV

10.1.1 Overview
10.1.2 HIV: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Tuberculosis

10.2.1 Overview
10.2.2 Tuberculosis: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Respiratory Infection

10.3.1 Overview
10.3.2 Respiratory Infection: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 Pneumonia

10.4.1 Overview
10.4.2 Pneumonia: Europe Anti-Infective Agents Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Anti-Infective Agents Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Anti-Infective Agents Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Anti-Infective Agents Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.1.2 UK: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.1.3 UK: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.1.4 UK: Europe Anti-Infective Agents Market Breakdown, by Indication

11.2.1.2 Germany: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.2.2 Germany: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.2.3 Germany: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.2.4 Germany: Europe Anti-Infective Agents Market Breakdown, by Indication

11.2.1.3 France: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.3.2 France: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.3.3 France: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.3.4 France: Europe Anti-Infective Agents Market Breakdown, by Indication

11.2.1.4 Russia: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.4.2 Russia: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.4.3 Russia: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.4.4 Russia: Europe Anti-Infective Agents Market Breakdown, by Indication

11.2.1.5 Italy: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.5.2 Italy: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.5.3 Italy: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.5.4 Italy: Europe Anti-Infective Agents Market Breakdown, by Indication

11.2.1.6 Rest of Europe: Europe Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Type
11.2.1.6.2 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Range
11.2.1.6.3 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.6.4 Rest of Europe: Europe Anti-Infective Agents Market Breakdown, by Indication

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Allergan Plc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bayer AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Boehringer Ingelheim International GmbH

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Bristol-Myers Squibb Company

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 F. Hoffmann-La Roche Ltd.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Gilead Sciences, Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 GlaxoSmithKline plc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Merck & Co., Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Novartis AG

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Anti-Infective Agents Market